2 completed, 1 recruiting, 1 unknown. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow ciprofibrate: new trials by email Literature Review of ciprofibrate trials Research Report on ciprofibrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia Atorvastatin, Simvastatin, Rozuvastatin - Atherosclerotic Cardiovascular Disease | Recruiting | Novartis Pharmaceuticals | 2382 | 2025-04-15 | 2026-11-13 | |
| Ciprofibrate and Pre-diabetes Ciprofibrate 100Mg Tablet, Placebo Oral Tablet - Myocardial Insulin Sensitivity, Impaired Glucose Metabolism | Phase 3 | Completed | Maastricht University Medical Center | 11 | 2018-11-01 | 2021-01-08 |
| Fish Oil Supplementation and Vascular Function in Hypertensive Patients With Hypertriglyceridemia DHA-EPA, Ciprofibrate - Hypertension, Hypertriglyceridemia | Phase 4 | Unknown | Hospital Universitario Pedro Ernesto | 52 | 2011-05-01 | 2011-11-29 |
| Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions Irbesartan, Ciprofibrate - Hypertension, Dyslipidemia | Phase 4 | Completed | Sanofi | 60 | 2005-02-01 | 2008-01-23 |
Hypertension (2) · Atherosclerosis (1) · Cardiovascular Diseases (1) · Dyslipidemias (1) · Hypertriglyceridemia (1)
Hospital Universitario Pedro Ernesto (1) · Maastricht University Medical Center (1) · Novartis Pharmaceuticals (1) · Sanofi (1)
Brazil (1) · Hungary (1) · Netherlands (1) · Russia (1)
Fernanda J Medeiros, PhD (1) · Marcela A Casanova, MSc (1) · Mario F Neves, MD, PhD (1) · Patrick Schrauwen, Professor (1) · Wille Oigman, MD, PhD (1)